A carregar...

Biosimilar Roadblock Removals Seem Tailor-Made for Trump/Democrats Agreement: Development of New Biosimilar Drugs and Marketing of Few Approved Drugs Stymied

The United States is lagging behind Europe in biosimilar use, and missing out on a wider range of medication options and huge savings in drug expenditures. What’s causing the holdup?

Na minha lista:
Detalhes bibliográficos
Publicado no:P T
Autor principal: Barlas, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: MediMedia USA, Inc. 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355054/
https://ncbi.nlm.nih.gov/pubmed/30766009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!